{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T07:13:45Z","timestamp":1762240425094,"version":"build-2065373602"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,3]]},"DOI":"10.7759\/cureus.96047","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T07:08:46Z","timestamp":1762240126000},"source":"Crossref","is-referenced-by-count":0,"title":["The Potential Role of Serum Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) as a Biomarker of Fibrosis in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)"],"prefix":"10.7759","author":[{"given":"Aalia","family":"Tahseen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchitra","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manaswini","family":"Mangaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manas K","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8327945","article-title":"Expression of matrix metalloproteinases and their tissue inhibitors in peripheral blood leukocytes and plasma of children with nonalcoholic fatty liver disease","volume":"2020","author":"Trojanek JB","year":"2020","unstructured":"Trojanek JB, Micha\u0142kiewicz J, Grzywa-Czuba R, et al.. Expression of matrix metalloproteinases and their tissue inhibitors in peripheral blood leukocytes and plasma of children with nonalcoholic fatty liver disease. Mediators Inflamm. 2020, 2020:8327945. 10.1155\/2020\/8327945","journal-title":"Mediators Inflamm"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng ML","year":"2023","unstructured":"Teng ML, Ng CH, Huang DQ, et al.. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023, 29:S32-42. 10.3350\/cmh.2022.0365","journal-title":"Clin Mol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.37897\/RMJ.2024.3.8","article-title":"Non-alcoholic fatty liver disease (NAFLD): a comparative study of clinico-socio-demographic characteristics among two diverse Indian population","volume":"71","author":"Sahoo P","year":"2024","unstructured":"Sahoo P, Singh M, Praharaj D, et al.. Non-alcoholic fatty liver disease (NAFLD): a comparative study of clinico-socio-demographic characteristics among two diverse Indian population. Rom Med J. 2024, 71:3. 10.37897\/RMJ.2024.3.8","journal-title":"Rom Med J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088184","article-title":"No correlation between TIMP2 -418 G>C polymorphism and increased risk of cancer: evidence from a meta-analysis","volume":"9","author":"Mandal RK","year":"2014","unstructured":"Mandal RK, Akhter N, Haque S, Panda AK, Mittal RD, Alqumber MA. No correlation between TIMP2 -418 G>C polymorphism and increased risk of cancer: evidence from a meta-analysis. PLoS One. 2014, 9:e88184. 10.1371\/journal.pone.0088184","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2017.11.011","article-title":"Matrix metalloproteinase functions in hepatic injury and fibrosis","volume":"68-69","author":"Roderfeld M","year":"2018","unstructured":"Roderfeld M. Matrix metalloproteinase functions in hepatic injury and fibrosis. Matrix Biol. 2018, 68-69:452-62. 10.1016\/j.matbio.2017.11.011","journal-title":"Matrix Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2005.07.008","article-title":"The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer","volume":"42","author":"O-Charoenrat P","year":"2006","unstructured":"O-Charoenrat P, Khantapura P. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. Oral Oncol. 2006, 42:257-67. 10.1016\/j.oraloncology.2005.07.008","journal-title":"Oral Oncol"},{"key":"ref7","article-title":"Fibroscan (transient elastography) for the measurement of liver fibrosis","volume":"8","author":"Afdhal NH","year":"2012","unstructured":"Afdhal NH. Fibroscan (transient elastography) for the measurement of liver fibrosis. Gastroenterol Hepatol (N Y). 2012, 8:605-7.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22603","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management","volume":"49","author":"Vuppalanchi R","year":"2009","unstructured":"Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology. 2009, 49:306-17. 10.1002\/hep.22603","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee JH","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, et al.. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010, 42:503-8. 10.1016\/j.dld.2009.08.002","journal-title":"Dig Liver Dis"},{"key":"ref10","article-title":"Basic & Clinical Biostatistics","author":"Dawson B","year":"2004","unstructured":"Dawson B, Trapp RG. Basic & Clinical Biostatistics. Lange Medical Books, New York, NY; 2004."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S411619","article-title":"The accuracy of ultrasound controlled attenuation parameter in diagnosing hepatic fat content","volume":"15","author":"Atzori S","year":"2023","unstructured":"Atzori S, Pasha Y, Maurice JB, Taylor-Robinson SD, Campbell L, Lim AK. The accuracy of ultrasound controlled attenuation parameter in diagnosing hepatic fat content. Hepat Med. 2023, 15:51-61. 10.2147\/HMER.S411619","journal-title":"Hepat Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-003-1178-8","article-title":"Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background","volume":"38","author":"Kojima S","year":"2003","unstructured":"Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol. 2003, 38:954-61. 10.1007\/s00535-003-1178-8","journal-title":"J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i47.6419","article-title":"Prevalence of fatty liver disease and its risk factors in the population of South China","volume":"13","author":"Zhou YJ","year":"2007","unstructured":"Zhou YJ, Li YY, Nie YQ, et al.. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol. 2007, 13:6419-24. 10.3748\/wjg.v13.i47.6419","journal-title":"World J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000235677","article-title":"Non-alcoholic fatty liver disease in older people","volume":"55","author":"Frith J","year":"2009","unstructured":"Frith J, Day CP, Henderson E, Burt AD, Newton JL. Non-alcoholic fatty liver disease in older people. Gerontology. 2009, 55:607-13. 10.1159\/000235677","journal-title":"Gerontology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200609000-00016","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults","volume":"40","author":"Chen CH","year":"2006","unstructured":"Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, Yueh SK. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol. 2006, 40:745-52. 10.1097\/00004836-200609000-00016","journal-title":"J Clin Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04047-0","article-title":"Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis","volume":"21","author":"Lu S","year":"2023","unstructured":"Lu S, Xie Q, Kuang M, et al.. Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis. J Transl Med. 2023, 21:192. 10.1186\/s12967-023-04047-0","journal-title":"J Transl Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/362147","article-title":"Role of body mass index, waist-to-height and waist-to-hip ratio in prediction of nonalcoholic fatty liver disease","volume":"2012","author":"Zheng RD","year":"2012","unstructured":"Zheng RD, Chen ZR, Chen JN, Lu YH, Chen J. Role of body mass index, waist-to-height and waist-to-hip ratio in prediction of nonalcoholic fatty liver disease. Gastroenterol Res Pract. 2012, 2012:362147. 10.1155\/2012\/362147","journal-title":"Gastroenterol Res Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116449","article-title":"Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly","volume":"9","author":"Roriz AKC","year":"2014","unstructured":"Roriz AKC, Passos LCS, de Oliveira CC, Eickemberg M, Moreira P de A, Sampaio LR. Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly. PLoS One. 2014, 9:e116449. 10.1371\/journal.pone.0116449","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.39575","article-title":"Body roundness index and waist-to-height ratio are strongly associated with non-alcoholic fatty liver disease: a population-based study","volume":"16","author":"Motamed N","year":"2016","unstructured":"Motamed N, Rabiee B, Hemasi GR, et al.. Body roundness index and waist-to-height ratio are strongly associated with non-alcoholic fatty liver disease: a population-based study. Hepat Mon. 2016, 16:e39575. 10.5812\/hepatmon.39575","journal-title":"Hepat Mon"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22350","article-title":"Visceral fat: a key mediator of steatohepatitis in metabolic liver disease","volume":"48","author":"van der Poorten D","year":"2008","unstructured":"van der Poorten D, Milner KL, Hui J, et al.. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology. 2008, 48:449-57. 10.1002\/hep.22350","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2019.08.002","article-title":"Non-alcoholic fatty liver disease in lean individuals","volume":"1","author":"Albhaisi S","year":"2019","unstructured":"Albhaisi S, Chowdhury A, Sanyal AJ. Non-alcoholic fatty liver disease in lean individuals. JHEP Rep. 2019, 1:329-41. 10.1016\/j.jhepr.2019.08.002","journal-title":"JHEP Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.01.050","article-title":"Heritability of nonalcoholic fatty liver disease","volume":"136","author":"Schwimmer JB","year":"2009","unstructured":"Schwimmer JB, Celedon MA, Lavine JE, et al.. Heritability of nonalcoholic fatty liver disease. Gastroenterology. 2009, 136:1585-92. 10.1053\/j.gastro.2009.01.050","journal-title":"Gastroenterology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1177\/2050312117745223","article-title":"Association between smoking and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"6","author":"Akhavan Rezayat A","year":"2018","unstructured":"Akhavan Rezayat A, Dadgar Moghadam M, Ghasemi Nour M, et al.. Association between smoking and non-alcoholic fatty liver disease: a systematic review and meta-analysis. SAGE Open Med. 2018, 6:2050312117745223. 10.1177\/2050312117745223","journal-title":"SAGE Open Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2188\/jea.je20120067","article-title":"Active smoking, passive smoking, and risk of nonalcoholic fatty liver disease (NAFLD): a population-based study in China","volume":"23","author":"Liu Y","year":"2013","unstructured":"Liu Y, Dai M, Bi Y, et al.. Active smoking, passive smoking, and risk of nonalcoholic fatty liver disease (NAFLD): a population-based study in China. J Epidemiol. 2013, 23:115-21. 10.2188\/jea.je20120067","journal-title":"J Epidemiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.942753","article-title":"Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality","volume":"9","author":"Ng CH","year":"2022","unstructured":"Ng CH, Wong ZY, Chew NW, et al.. Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality. Front Cardiovasc Med. 2022, 9:942753. 10.3389\/fcvm.2022.942753","journal-title":"Front Cardiovasc Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.129112","article-title":"The potential impact of family history of metabolic syndrome and risk of type 2 diabetes mellitus: in a highly endogamous population","volume":"18","author":"Bener A","year":"2014","unstructured":"Bener A, Darwish S, Al-Hamaq AO, Yousafzai MT, Nasralla EA. The potential impact of family history of metabolic syndrome and risk of type 2 diabetes mellitus: in a highly endogamous population. Indian J Endocrinol Metab. 2014, 18:202-9. 10.4103\/2230-8210.129112","journal-title":"Indian J Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher G","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021, 18:599-612. 10.1038\/s41575-021-00448-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2010.04.005","article-title":"Relationship between white blood cell count and nonalcoholic fatty liver disease","volume":"42","author":"Lee YJ","year":"2010","unstructured":"Lee YJ, Lee HR, Shim JY, Moon BS, Lee JH, Kim JK. Relationship between white blood cell count and nonalcoholic fatty liver disease. Dig Liver Dis. 2010, 42:888-94. 10.1016\/j.dld.2010.04.005","journal-title":"Dig Liver Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.163172","article-title":"Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes","volume":"19","author":"Sanyal D","year":"2015","unstructured":"Sanyal D, Mukherjee P, Raychaudhuri M, Ghosh S, Mukherjee S, Chowdhury S. Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes. Indian J Endocrinol Metab. 2015, 19:597-601. 10.4103\/2230-8210.163172","journal-title":"Indian J Endocrinol Metab"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.13005\/bbra\/2876","article-title":"A correlational study of hepatic steatosis (fatty liver disease) and liver enzymes (ALT, AST, GGT) in the scenario of insulin resistance among young medicos","volume":"15","author":"Mukherjee S","year":"2021","unstructured":"Mukherjee S, Saha S, Banerjee U, et al.. A correlational study of hepatic steatosis (fatty liver disease) and liver enzymes (ALT, AST, GGT) in the scenario of insulin resistance among young medicos. Biosci Biotechnol Res Asia. 2021, 15:717-25. 10.13005\/bbra\/2876","journal-title":"Biosci Biotechnol Res Asia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/385091-the-potential-role-of-serum-tissue-inhibitor-of-metalloproteinase-2-timp-2-as-a-biomarker-of-fibrosis-in-patients-with-metabolic-dysfunction-associated-fatty-liver-disease-mafld","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T07:08:47Z","timestamp":1762240127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/385091-the-potential-role-of-serum-tissue-inhibitor-of-metalloproteinase-2-timp-2-as-a-biomarker-of-fibrosis-in-patients-with-metabolic-dysfunction-associated-fatty-liver-disease-mafld"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.96047","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,3]]}}}